Reshaping the Battlefield: Reprogramming the Melanoma Tumour Microenvironment (TME) by Anti-CTLA-4, Anti-PD-1, and Anti-PD-L1 Monotherapy and Combination Therapy: A Systematic Review and Meta-Analysis of Preclinical and Clinical Evidence

Immune checkpoint inhibitors (ICIs), comprising anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), anti-programmed cell death protein 1 (PD-1), and anti-programmed death-ligand 1 (PD-L1), have transformed melanoma therapy, yet the tumour microenvironment (TME), the pivotal biological interfa...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Vasileios Alexandros Karakousis, Stylianos Mantalovas, Vasiliki Christina Karakousi, Ioannis S. Vizirianakis, Theodora Papamitsou, Leonidas Pavlidis, Christophoros S. Kosmidis
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-06-01
Edice:	Cells
Témata:	melanoma tumour microenvironment immune checkpoint inhibitors CTLA-4 PD-1 PD-L1
On-line přístup:	https://www.mdpi.com/2073-4409/15/13/1182
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!